| 4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxylic acid |
非奈利酮中间体 |
1050477-45-6 |
| (4aS,9bR)-6-bromo-1H,2H,3H,4H,4aH,5H,9bH-pyrido[4,3-b]indole |
(4AS,9BR)-6-溴-1H,2H,3H,4H,4AH,5H,9BH-吡啶[4,3-B]吲哚,(2S)-2-羟基-2-苯基乙酸盐 |
1059630-13-5 |
| (6bR,10aS)-Ethyl 3-methyl-2-oxo-2,3,6b,7,10,10a-hexahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline-8(9H)-carboxylate |
313369-25-4 |
313369-25-4 |
| 4-[3-(4-Cyano-3-trifluoromethylphenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl]-N-methylbenzamide |
4-[3-(4-氰基-3-三氟甲基苯基)-5,5-二甲基-4-氧代-2-硫代咪唑烷-1-基]-N-甲基苯甲酰胺 |
915087-16-0 |
| (6bR,10aS)-3-Methyl-2,3,6b,7,8,9,10,10a-octahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline |
313368-85-3 |
313368-85-3 |
| (4aS,9bR)-6-bromo-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indole |
（4aS,9bR）-6-溴-2,3,4,4a,5,9b-六氢-1H-吡啶并[4,3-B]吲哚 |
1059630-07-7 |
| EnzalutaMide IMpurity |
恩杂鲁胺杂质 |
1839619-50-9 |
| Parecoxib Sodium Impurity 14 |
间位帕瑞昔布 |
1709956-89-7 |
| ITI-722 |
卢美哌隆 |
313368-91-1 |
| daprodustat,GSK1278863 |
达普司他 |
960539-70-2 |
| N-desMethyl EnzalutaMide |
4-[3-[4-氰基-3-(三氟甲基)苯基]-5,5-二甲基-4-氧代-2-硫代-1-咪唑烷基]-2-氟苯甲酰胺 |
1242137-16-1 |
| lifitegrast |
立他司特 |
1025967-78-5 |
| Finerenone (BAY 94-8862) |
非奈利酮 |
1050477-31-0 |
| Afatinib |
阿法替尼 |
850140-72-6 |
| 4-amino-7-iodopyrrolo[2,1-f][1,2,4]triazine |
7-碘吡咯并[2,1-F][1,2,4]三嗪-4-胺 |
1770840-43-1 |
| 2,4-dichloro-3-isocyanato-1,5-dimethoxybenzene |
2,6-二氯-3,5-二甲氧基苯基异氰酸酯 |
872511-32-5 |
| (2-((2,5-Dichloropyrimidin-4-yl)amino)phenyl)dimethylphosphine oxide |
AP26113中间体1 |
1197953-49-3 |
| 2,2,14,14-tetramethyl-8-oxopentadecanedioic acid |
2,2,14,14-四甲基-8-氧代十五烷二酸 |
413624-71-2 |
| ethyl-2,2-dimethyl-7-bromoheptanoate |
7-溴-2,2-二甲基庚酸乙酯 |
123469-92-1 |
| 4-AMINO-5-CHLORO-2-METHOXYBENZOIC ACID |
4-氨基-5-氯-2-甲氧基苯甲酸 |
7206-70-4 |
QQ
微信
